Feasibility of a Smart Label–Enabled Remote Therapeutic Monitoring Intervention to Support Cyclin-Dependent Kinase 4/6 Inhibitor Adherence in Breast Cancer Care
A smart label-enabled RTM mHealth intervention exceeded feasibility and usability benchmarks and showed promise for supporting CDKI adherence and symptom management.
Authors
- Tamar Sapir (ORCID: https://orcid.org/0000-0003-1135-427X)
- Gelareh Sadigh (ORCID: https://orcid.org/0000-0003-3233-1878)
- Ilana Graetz (ORCID: https://orcid.org/0000-0003-3664-5815)
- Cherilyn L. Heggen (ORCID: https://orcid.org/0000-0002-8941-0334)
- Jane Meisel (ORCID: https://orcid.org/0000-0002-2642-865X)
- Kelly E. McKinnon (ORCID: https://orcid.org/0000-0002-5956-0198)
- Clara Cai (ORCID: https://orcid.org/0009-0009-0149-902X)
- Samuel Hernández
- Sara Arshad (ORCID: https://orcid.org/0009-0009-0754-3159)
- Freddie Yang
- Jeffrey Carter
Institutions
- Emory University (US)
- University of Georgia (US)
- University of California, Irvine (US)
- Augusta University (US)
Publication Details
- Journal
- JCO Clinical Cancer Informatics
- Published
- 2025-11-01
- DOI
- https://doi.org/10.1200/cci-25-00152
- Primary Topic
- Advanced Breast Cancer Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00